成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1)

2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1) Struktur
2134096-06-1
CAS-Nr.
2134096-06-1
Englisch Name:
2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1)
Synonyma:
Almonertinib mesylate;Almonertinib mesylate, 10 mM in DMSO;N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide methanesulfonate;2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1);Almonertinib,EGFR tyrosine kinase inhibitor,Inhibitor,HER1,ErbB-1,third-generation,HS-10296,HS 10296,orally available,Almonertinib mesylate,inhibit,Epidermal growth factor receptor,irreversible,HS10296,non-small cell lung cancer,EGFR
CBNumber:
CB89318825
Summenformel:
C31H39N7O5S
Molgewicht:
621.76
MOL-Datei:
2134096-06-1.mol

2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1) Eigenschaften

storage temp. 
4°C, away from moisture
L?slichkeit
DMSO : 31.25 mg/mL (50.26 mM; ultrasonic and warming and heat to 60°C)
Aggregatzustand
Solid
Farbe
Light yellow to yellow

Sicherheit

2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1) Chemische Eigenschaften,Einsatz,Produktion Methoden

2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 22)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32965 60
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 32161 58
Nanjing Doge Biomedical Technology Co., Ltd
+86-25-58227606 +86-15305155328
sales@dogechemical.com China 4128 58
TargetMol Chemicals Inc.

support@targetmol.com United States 38631 58
Chemtour Biotech Co., Ltd
+8617327281506
market@chemtour.com China 1519 58
Aladdin Scientific
+1-+1(833)-552-7181
sales@aladdinsci.com United States 52924 58
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266
China 4573 55
Hubei Chuangliankangcheng Pharmaceutical Co., Ltd. 027-65388397 18164111589
3321478047@qq.com China 1993 55
ShangHai Biochempartner Co.,Ltd 17754423994 17754423994
2853530910@QQ.com China 8011 62
Shanghai Chaolan Chemical Technology Center 021-QQ:65489617 15618227136
Sales@ATKchemical.com China 7312 58

  • 2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-, compd. with methanesulfonate (1:1)
  • Almonertinib mesylate
  • Almonertinib,EGFR tyrosine kinase inhibitor,Inhibitor,HER1,ErbB-1,third-generation,HS-10296,HS 10296,orally available,Almonertinib mesylate,inhibit,Epidermal growth factor receptor,irreversible,HS10296,non-small cell lung cancer,EGFR
  • N-(5-((4-(1-cyclopropyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide methanesulfonate
  • Almonertinib mesylate, 10 mM in DMSO
  • 2134096-06-1
  • C31H39N7O5S
Copyright 2019 ? ChemicalBook. All rights reserved